rBet v 1

BIOLOGICAL4 trials

Sponsors

Stallergenes Greer, Medical University of Vienna

Conditions

Birch Pollen AllergyBirch Pollen Related Apple AllergyBirch Pollen-Related RhinoconjunctivitisBirch Pollen-related RhinoconjunctivitisRhinitis, Allergic, Seasonal

Phase 1

Safety, Tolerability and Pharmacodynamic Effects of Sublingual Immunotherapy (Tablets) With Recombinant Bet v1

CompletedNCT00396149

Stallergenes GreerBirch Pollen-Related Rhinoconjunctivitis, Rhinitis, Allergic, Seasonal

Start: 2006-11-30End: 2007-06-30Updated: 2013-06-27

Safety and Tolerability Study of rBet v1 SLIT Tablets

CompletedNCT00889460

Stallergenes GreerBirch Pollen-Related Rhinoconjunctivitis, Rhinitis, Allergic, Seasonal

Start: 2007-11-30End: 2008-04-30Updated: 2009-04-29

Phase 2

Study of rBet v1 Tablets

CompletedNCT00901914

Stallergenes GreerBirch Pollen-related Rhinoconjunctivitis, Rhinitis, Allergic, Seasonal

Start: 2008-10-31End: 2009-08-31Updated: 2013-06-27

Sublingual Immunotherapy of Birch Pollen Associated Apple Allergy

CompletedNCT01449786

Medical University of ViennaBirch Pollen Allergy, Birch Pollen Related Apple Allergy

Start: 2012-03-14End: 2016-12-20Updated: 2017-04-13